Verity Asset Management, Inc. Meridian Bioscience Inc Transaction History

Verity Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	BUY	$10.88 - $17.6 $38,950 - $63,008	3,580 Added 15.07%	27,338 $435,000
Q1 2019 May 13, 2019	BUY	$15.51 - $17.61 $38,356 - $43,549	2,473 Added 11.62%	23,758 $418,000
Q4 2018 Feb 12, 2019	SELL	$14.52 - $19.72 $47,335 - $64,287	-3,260 Reduced 13.28%	21,285 $370,000
Q3 2018 Nov 13, 2018	SELL	$14.85 - $16.35 $41,476 - $45,665	-2,793 Reduced 10.22%	24,545 $366,000
Q2 2018 Aug 07, 2018	BUY	$13.8 - $16.8 $87,478 - $106,495	6,339 Added 30.19%	27,338 $435,000
Q1 2018 May 02, 2018	BUY	$13.8 - $16.2 $148,101 - $173,858	10,732 Added 104.53%	20,999 $298,000
Q4 2017 Feb 07, 2018	BUY	$13.55 - $15.8 $139,117 - $162,218	10,267	10,267 $161,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Verity Asset Management, Inc. with notifications on news.